Clinical trial Recruiting at 2 sites Observational Ages 14 to 35

Hilo band versus 24-hour ABPM in young people with high or normal blood pressure

Official title: A Multi-centre Study Evaluating the Performance and Acceptance of the Hilo Band Cuffless Blood Pressure Medical Device in the Normo-, Hypo- and Hyper-tensive Young Population: a Comparison With the 24-h Ambulatory Blood Pressure Monitoring (ABPM)

Run by Ente Ospedaliero Cantonale, Bellinzona · NCT07072689 · Data updated 2026-11-12

This study tests whether the Hilo band cuffless blood pressure monitor can match the readings of 24-hour ABPM in adolescents and young adults with hypertension or risk factors.

More Hypertension trials

Quick facts

Study typeObservational
Ages14 Years to 35 Years
SexAll
Enrollment60 (estimated)
SponsorEnte Ospedaliero Cantonale, Bellinzona
Academic / other
Locations2 sites (Bellinzona and 1 other locations)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedDecember 1, 2028
Study endsDecember 1, 2028
Registry record updatedOctober 13, 2026
Trial IDNCT07072689 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are 14–35 years old who need 24-hour BP monitoring and can use a connected device and mobile phone.

Probably not a fit

Patients with arrhythmias, silicone allergies, or conditions preventing use of the device may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a multi-center observational study evaluating the performance and acceptance of the Hilo band, a cuffless BP device, against the 24-hour ABPM in 40 participants aged 14 to 35. The study uses a non-interventional design to compare systolic and diastolic BP measurements from the Hilo band with those from ABPM over a 24-hour period. Participants include adolescents and young adults with a clinical indication for 24-hour BP monitoring, recruited at Bellinzona and Geneva. The aim is to assess accuracy, usability, and potential advantages of long-term, comfortable, cuffless monitoring in a real-world setting. Ethically approved and conducted in collaboration with SwissPedNet and the involved hospitals.

Why it matters

Potential benefit: If successful, the Hilo band could offer a more comfortable and practical way to monitor blood pressure over 24 hours for young people.

How similar studies have gone: Prior studies of cuffless BP devices show mixed results; this study provides targeted data in a younger, active population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Population 1:

* Informed Consent signed by the subject/legal representative
* 14-20 years of age
* Clinical indication to receive a 24-h ABPM measurement
* Functional internet phone connection
* Negative pregnancy test, ongoing anti-conceptive treatment or declaration of the subject not being pregnant

Population 2:

* Informed Consent signed by the subject
* 21-35 years of age
* Clinical indication for receiving a 24-hour blood pressure measurement
* Functional internet phone connection
* Negative pregnancy test, ongoing anti-conceptive treatment or declaration of the subject not being pregnant

Population 3

* Informed Consent signed by the subject
* 21-35 years of age
* Functional internet phone connection
* Negative pregnancy test, ongoing anti-conceptive treatment or declaration of the subject not being pregnant

Exclusion Criteria for both population 1, 2 and 3:

* Allergies to silicone
* Atrial fibrillation
* Subjects with arrhythmia
* Patients suffering from pathologies that systematically reduce peripheral perfusion including Raynaud's disease, diabetes, renal dysfunctions (eGFR \< 30mL / min / 1.73 m2), untreated hyper-/ hypothyroidism, pheochromocytoma, or arteriovenous fistula
* Interarm Systolic Blood Pressure (SBP) difference over 10% or Diastolic Blood Pressure (DBP) difference over 10%
* Arm paralysis
* Amputated upper limb
* Arm trembling or shivering
* Upper arm circumference \> 64 cm
* Wrist circumference \> 22 cm
* Exfoliative skin diseases and lymphoedema or damaged/injured skin at the wrist
* Pregnant women
* Individuals with lack of judgment/mental illness
* Sleepwalking and severe insomnia
* Pica disorder

Where it's running

  • Ente Ospedaliero Cantonale
    Bellinzona, Switzerland
    Recruiting
  • Geneva University Hospitals (HUG)
    Geneva, Switzerland
    Recruiting

Study contacts

  • Principal investigator: Giacomo Simonetti, Prof. Dr. med — Ente Ospedaliero cantonale (EOC)
  • Study coordinator: Lisa Pedrotti, MSc
  • Email: lisa.pedrotti@eoc.ch
  • Phone: +41918119738

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.